Playback speed
10 seconds
ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Efficacy of Brentuximab Vedotin & Nivolumab +/- R-CHP for Untreated PMBL
By
ASCO 2022 Conference Coverage
FEATURING
Raphael Steiner
By
ASCO 2022 Conference Coverage
FEATURING
Raphael Steiner
413 views
June 7, 2022
Comments 0
Login to view comments.
Click here to Login